Galapon, Hannah .

HRN: 27-57-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2025
CEFUROXIME 750MG (VIAL)
07/31/2025
08/07/2025
IV
400mg
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: